Creating a ‘new world’ to bring about next-gen antibiotics
A low volume, high margin business model will facilitate the development of new antibiotics and see big pharma return to the space, suggests Entasis CEO.
Archives for February 20, 2019
‘The magic balance’: Diverse advisory boards guide clinical trial design
With the recent marriage between technology and science aimed at innovating aspects of clinical trials panels composed of experts from fields outside of pharma could prove to be impactful.